ABSTRACT

Hypolipidemic Drugs ...............................................................................32 2.2.1 HMG-CoA Reductase Inhibitors (Statins)....................................33 2.2.2 Fibric Acid Derivatives (Fibrates).................................................34 2.2.3 Bile Acid Transport Inhibitors ......................................................35 2.2.4 Niacin (Nicotinic Acid) .................................................................36 2.2.5 Cholesterol Absorption Inhibitors .................................................37 2.2.6 Emerging and Future Directions in Hypolipidemic Therapy.......37